NMR screening in drug discovery

Current Opinion in Biotechnology

Volumn 10, Issue 1, 1999, Pages 54-58

  Moore, Jonathan M ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROTEIN; STROMELYSIN;

DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 0032900490     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(99)80010-X     Document Type: Article

References (25)

1. Campbell ID, Dwek RA Biological Spectroscopy. 1984;Benjamin/Cummings, Menlo Park.
2. Dwek RA Nuclear Magnetic Resonance in Biochemistry. 1973;Clarendon Press, Oxford.
3. James TL Nuclear Magnetic Resonance in Biochemistry. 1975;Academic Press, New York.
4. Ni F Recent developments in transferred NOE methods. Prog Nucl Mag Reson Spectrosc. 26:1994;517-606.
5. Shuker SB, Hajduk PJ, Meadows RP, Fesik SW Discovering high-affinity ligands for proteins: SAR by NMR. Science. 274:1996;1531-1534.
6. Murcko MA Recent advances in ligand design methods. Lipkowitz KB, Boyd DB Reviews in Computational Chemistry, vol 11. 1997;1-66 Wiley and Sons, New York.
7. Kuntz ID Structure-based molecular design. Acc Chem Res. 27:1994;117-123.
8. Murcko MA An introduction to de novo ligand design. Charifson PS Practical Application of Computer-Aided Drug Design. 1997;305-354 Marcel Dekker, Inc, New York.
9. Mattos C, Ringe D Locating and characterizing binding sites on proteins. Nat Biotechnol. 14:1996;595-599.
10. Allen KN, Bellamacina CR, Ding X, Jeffery CJ, Mattos C, Petsko GA An experimental approach to mapping the binding surfaces of crystalline proteins. J Phys Chem. 100:1996;2605-2611.
11. Liepinsh E, Otting G Organic solvents identify specific ligand binding sites on protein surfaces. Nat Biotechnol. 15:1997;264-268. An NMR study to examine the binding of solvent molecules to lysozyme; the solution equivalent of the MSCS technique for crystal structures [9,10]. Results indicate that most solvent molecules found to occupy protein sites in the crystal do not bind to high affinity sites, but rather bind weakly to sites formed due to crystal packing. NMR methods detect only the higher affinity ligand molecules, and do not suffer from the artificial occupancy problems of MSCS.
12. Hajduk PJ, Sheppard G, Nettesheim DG, Olejniczak ET, Shuker SB, Meadows RP Discovery of potent non-peptide inhibitors of stromelysin using SAR by NMR. J Am Chem Soc. 119:1997;5818-5827. Application of the SAR by NMR method to design two potent (<25 nM) inhibitors of stromelysin. This work provides a step by step description of the design protocol and is an excellent source of information for scientists working directly in the field.
13. ••], the design protocol is described in detail. This work is of special importance because lead compounds were obtained for a target for which little chemistry was known.
14. Armistead DA, Badia MC, Deininger DD, Duffy JP, Saunders JO, Tung RD Design, synthesis and structure of non-macrocylic inhibitors of FKBP-12, the major binding protein for the immunosuppressant FK506. Acta Crystallogr. D51:1995;522-528.
15. Hagmann WK, Lark MW, Becker JW Inhibition of matrix metalloproteinases. Annu Rep Med Chem. 31:1996;231-240.
16. Wahl RC, Dunlap RP Biochemistry and inhibition of collagenase and stromelysin. Annu Rep Med Chem. 25:1989;177-184.
17. Meyer B, Weimar T, Peters T Screening mixtures for biological activity by NMR. Eur J Biochem. 246:1997;705-709. An excellent example of how the transferred NOE experiment may be used to screen libraries of small molecules against a protein target. In this paper, two mixtures of oligosaccharides were screened against Aleuria aurantia agglutinin. From the 2D spectra, a single binding ligand from each mixture could be readily identified and characterized.
18. Lin M, Shapiro MJ Mixture analysis in combinatorial chemistry. Application of diffusion-resolved NMR spectroscopy. J Org Chem. 61:1996;7617-7619.
19. Lin M, Shapiro MJ, Wareing JR Screening mixtures by affinity NMR. J Org Chem. 62:1997;8930-8931.
20. Lin ML, Shapiro MJ, Wareing JR Diffusion-edited NMR-affinity NMR for direct observation of molecular interactions. J Am Chem Soc. 119:1997;5249-5250.
21. Gonnella N, Lin M, Shapiro MJ, Wareing JR, Zhang X Isotope-filtered affinity NMR. J Magn Reson. 131:1998;336-338.
22. Hajduk PJ, Olejniczak ET, Fesik SW One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules. J Am Chem Soc. 119:1997;12257-12261. A practical description of how NMR relaxation and diffusion difference methods, well known techniques for the study of macromolecule/small molecule interactions, may be used to screen large libraries of small molecules against a macromolecular target.
23. Bemis GW, Murcko MA The properties of known drugs. 1. Molecular frameworks. J Med Chem. 39:1996;2887-2893.
24. Walters WP, Stahl MT, Murcko MA Virtual screening-an overview. Drug Discov Today. 3:1998;160-178.
25. Armistead DA, Boger JS, Meyers HV, Saunders JO, Tung RD: Immunosuppressive compounds. US Patent 1993, no 5 192 773.